Blmf, Lenalidomide and Dexamethasone in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
Clinical trial NCT04808037 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04808037
- Sponsor
- Hellenic Society of Hematology
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-22
- Primary completion
- 2028-09-08
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.